[HTML][HTML] Intervention with citrus flavonoids reverses obesity and improves metabolic syndrome and atherosclerosis in obese Ldlr−/− mice

AC Burke, BG Sutherland, DE Telford… - Journal of Lipid …, 2018 - ASBMB
Obesity and its associated metabolic dysfunction and cardiovascular disease risk represent
a leading cause of adult morbidity worldwide. Currently available pharmacological therapies …

Preventive and ameliorating effects of citrus D-limonene on dyslipidemia and hyperglycemia in mice with high-fat diet-induced obesity

L Jing, Y Zhang, S Fan, M Gu, Y Guan, X Lu… - European journal of …, 2013 - Elsevier
Abstract d-limonene is a major constituent in citrus essential oil, which is used in various
foods as a flavoring agent. Recently, d-limonene has been reported to alleviate fatty liver …

Citrus flavonoids as regulators of lipoprotein metabolism and atherosclerosis

EE Mulvihill, AC Burke, MW Huff - Annual review of nutrition, 2016 - annualreviews.org
Citrus flavonoids are polyphenolic compounds with significant biological properties. This
review summarizes recent advances in understanding the ability of citrus flavonoids to …

[HTML][HTML] Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr−/− mice [S]

JM Assini, EE Mulvihill, BG Sutherland, DE Telford… - Journal of lipid …, 2013 - ASBMB
Obesity-associated chronic inflammation contributes to metabolic dysfunction and
propagates atherosclerosis. Recent evidence suggests that increased dietary cholesterol …

Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat–fed low-density lipoprotein receptor–null mice

EE Mulvihill, JM Assini, BG Sutherland… - … , and vascular biology, 2010 - Am Heart Assoc
Objective—Naringenin is a citrus flavonoid that potently inhibits the assembly and secretion
of apolipoprotein B100–containing lipoproteins in cultured hepatocytes and improves the …

Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor–null mice with diet-induced insulin resistance

EE Mulvihill, EM Allister, BG Sutherland, DE Telford… - Diabetes, 2009 - Am Diabetes Assoc
OBJECTIVE The global epidemic of metabolic syndrome and its complications demands
rapid evaluation of new and accessible interventions. Insulin resistance is the central …

Protection from Metabolic Dysregulation, Obesity, and Atherosclerosis by Citrus Flavonoids: Activation of Hepatic PGC1α‐Mediated Fatty Acid Oxidation

EE Mulvihill, MW Huff - PPAR research, 2012 - Wiley Online Library
Studies in a multitude of models including cell culture, animal and clinical studies
demonstrate that citrus‐derived flavonoids have therapeutic potential to attenuate …

Grape seed proanthocyanidins correct dyslipidemia associated with a high-fat diet in rats and repress genes controlling lipogenesis and VLDL assembling in liver

H Quesada, JM Del Bas, D Pajuelo, S Díaz… - International journal of …, 2009 - nature.com
Objective: To determine whether proanthocyanidins can protect against dyslipidemia
induced by a high-fat diet (HFD) and to address the mechanisms that underlie this …

Citrus flavonoids and lipid metabolism

JM Assini, EE Mulvihill, MW Huff - Current opinion in lipidology, 2013 - journals.lww.com
These recent studies suggest an important role of citrus flavonoids in the treatment of
dyslipidemia, insulin resistance, hepatic steatosis, obesity and atherosclerosis. The …

Combination of citrus polymethoxyflavones, green tea polyphenols, and Lychee extracts suppresses obesity and hepatic steatosis in high‐fat diet induced obese mice

MH Pan, G Yang, S Li, MY Li, ML Tsai… - Molecular nutrition & …, 2017 - Wiley Online Library
Scope SlimTrym® is a formulated product composed of citrus polymethoxyflavones (PMFs),
green tea extract, and lychee extract. We investigated the effect of dietary SlimTrym® on diet …